This trial will compare two types of radiation therapy for men with prostate cancer that has come back after surgery. One type is given over 4 weeks and the other over 2 weeks. The study will look at side effects and health scores.
- Prostate Cancer
1 Primary · 4 Secondary · Reporting Duration: Through study completion, an average of 10 years
2 Treatment Groups
ARM 1 - 2 weeks
1 of 2
ARM 2 - 4 weeks
1 of 2
134 Total Participants · 2 Treatment Groups
Primary Treatment: ARM 1 - 2 weeks · No Placebo Group · Phase 2
Who is running the clinical trial?
Age 18 - 90 · Male Participants · 6 Total Inclusion CriteriaMark “Yes” if the following statements are true for you:
Frequently Asked Questions
How do I sign up for the clinical trial?
"Prostate cancer patients that are between 18 and 90 years old may be eligible for this study. The research team is currently trying to enroll 134 people in total." - Anonymous Online Contributor
How many people can enroll in this clinical trial?
"That is accurate. The listing for this clinical trial on clinicaltrials.gov says that it is still looking for patients to enroll. This particular study was posted on September 24th, 2020 and updated as recently as June 29th, 2022. They are hoping to have 134 people participate at a single location." - Anonymous Online Contributor
Are young adults eligible to participate in this experiment?
"As long as potential patients are above the age of 18 and have not yet reached their 90th birthday, they will be eligible for this trial." - Anonymous Online Contributor
Is there a high risk of developing complications from ARM 1 - 2 weeks after treatment?
"While there is some safety data from Phase 2 trials, there is none currently supporting efficacy. Therefore, our team has rated the ARM 1-2 weeks as a 2." - Anonymous Online Contributor
Are we still enrolling people in this experiment?
"Yes, the information on clinicaltrials.gov indicates that this clinical trial is actively recruiting patients. The clinical trial was originally posted on 9/24/2020 and was most recently updated on 6/29/2022. The clinical trial is enrolling 134 participants across 1 locations" - Anonymous Online Contributor